Clínica Zabala

Ciudad de Buenos Aires, AR C1426AAM

0 studies enrolling now · 2 studies all time

What they study most

COVID-19

Studies at this site

• A Study of Baricitinib (LY3009104) in Participants With COVID-19 — Completed
• A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness — Completed